Markets › India › BOM › EMMESSA

Emmessar Biotech & Nutrition Limited

BOM:EMMESSAHealthcare

₹21.33−2.25%At closeAt close · Tue 20 Oct · ≈ AED 0.8241 · Market cap $1.15M

INR millions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Net income	22.5	9.3	9.7	8.1	3.2	4.4	+37.9%
Depreciation & amortization	0.6	0.9	0.9	1.0	1.0	1.0	+2.6%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	(16.1)	17.6	(5.0)	2.4	(3.4)	(0.9)	+74.1%
Operating cash flow	4.7	22.7	3.8	6.4	2.2	6.6	+194.1%
Capital expenditure	(0.0)	(3.1)	(0.3)	0.0	0.0	(0.1)	—
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	—
Investing cash flow	0.1	(26.1)	(5.5)	(6.4)	(2.3)	(6.1)	−167.0%
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	0.0	0.0	0.0	0.3	(1.2)	(0.2)	+81.3%
Financing cash flow	0.0	0.0	0.0	0.3	0.0	(0.2)	−725.7%
Free cash flow	4.7	19.6	3.5	6.4	2.2	6.5	+190.3%
Net change in cash	4.8	(3.4)	(1.7)	0.0	(0.0)	73.1	+304512.5%

INR millionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.